Narcolepsy is a chronic neurological sleep disorder that affects the brain’s ability to regulate sleep and wakefulness. The most recognisable feature is severe daytime sleepiness, sometimes accompanied by sudden, uncontrollable episodes of sleep. Although the exact cause is not established in every case, research points to a combination of biological, genetic and possibly immune-related factors.
What is narcolepsy?
Narcolepsy causes an unstable boundary between sleep and wakefulness. A person may feel overwhelmingly sleepy during the day, fall asleep during ordinary activities, or experience dream-related symptoms while falling asleep or waking. Night-time sleep can also be disrupted, even though the main problem is often excessive sleepiness during the day.
There are two commonly recognised forms:
- Narcolepsy type 1: Usually involves cataplexy, which is a sudden loss of muscle tone triggered by emotions such as laughter, excitement or surprise. It is often associated with very low levels of hypocretin.
- Narcolepsy type 2: Involves excessive daytime sleepiness without cataplexy. Hypocretin levels are often not markedly reduced.
The role of hypocretin, also called orexin
One of the strongest biological explanations for narcolepsy type 1 is the loss of brain cells that produce hypocretin, also known as orexin. This chemical messenger helps maintain wakefulness and coordinate the timing of sleep, waking and rapid eye movement (REM) sleep.
When hypocretin signalling is severely reduced, the normal separation between wakefulness and sleep can become unstable. This may contribute to sudden sleep episodes, abnormal REM-sleep features, and cataplexy. The loss of these cells appears to be particularly important in type 1 narcolepsy, while the underlying biology of type 2 is less clearly understood.
Could narcolepsy involve the immune system?
Evidence suggests that, in many people with narcolepsy, the immune system may play a role in damaging or eliminating hypocretin-producing neurons. This is often described as an immune-mediated or autoimmune process. Immune-related genetic differences and inflammatory findings support this possibility, but they do not explain every case completely.
The immune hypothesis does not mean narcolepsy is contagious. It also does not mean that a particular infection or other event will cause narcolepsy in everyone exposed to it. These factors may be relevant only in people with an underlying susceptibility.
Is narcolepsy genetic?
Genetics can influence the likelihood of developing narcolepsy, but narcolepsy is not determined by a single gene. A specific immune-system-related marker, HLA-DQB1*06:02, is strongly associated with narcolepsy type 1. However, most people who carry this marker do not develop narcolepsy, and many people with narcolepsy have no known family history.
This means that inherited traits are best understood as risk factors rather than a direct cause. Other genetic variations may also affect susceptibility, and environmental factors could contribute to the start of the disease process in some individuals.
Possible triggers and factors linked with onset
Narcolepsy may appear after a period in which the immune system has been activated, such as an infection. Severe stress has also been discussed as a possible contributing factor, although stress by itself is not considered a complete explanation for narcolepsy. Rarely, narcolepsy-like symptoms can occur after damage to areas of the brain involved in sleep regulation.
A reported increase in narcolepsy after the 2009 H1N1 pandemic in certain countries was linked to a specific vaccine formulation and particular circumstances. This was a rare, context-specific association and does not mean that vaccines generally cause narcolepsy. The available information does not support the idea that narcolepsy can be deliberately acquired, caught from another person, or caused simply by poor sleep habits or laziness.
Symptoms that may point to narcolepsy
Excessive daytime sleepiness is usually the central symptom. A sudden, irresistible episode of sleep may happen while talking, eating, reading or performing another routine activity. These episodes can create serious safety risks, especially when driving or operating equipment.
Other possible symptoms include:
- Cataplexy, or brief muscle weakness while remaining conscious
- Sleep paralysis when falling asleep or waking
- Vivid dreamlike hallucinations at the transition between sleep and wakefulness
- Disturbed or fragmented night-time sleep
Symptoms may develop gradually or become noticeable more suddenly. Their presence does not prove that someone has narcolepsy, since other sleep, neurological and medical conditions can cause similar problems.
How narcolepsy is diagnosed and managed
Diagnosis usually involves assessment by a qualified sleep clinician. An overnight sleep study, called polysomnography, may be followed by a multiple sleep latency test to measure how quickly a person falls asleep and whether REM sleep occurs unusually soon. Hypocretin testing in cerebrospinal fluid may be considered in selected cases.
Treatment is tailored to the person’s symptoms and may include scheduled short naps, consistent sleep routines, wake-promoting or stimulant medication, and treatments for cataplexy or other REM-related symptoms. Workplace or school adjustments can also improve safety and daily functioning. Anyone experiencing repeated sleep attacks, profound daytime sleepiness, or sudden muscle weakness should seek medical evaluation rather than assuming the symptoms are caused by ordinary tiredness.
